Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D012008:Recurrence; D013488:Suppositories; D013997:Time Factors; D014230:Triazoles / Q000008:administration & dosage*; D014621:Vagina
D000935:Antifungal Agents; D013488:Suppositories; D014230:Triazoles; C037815:terconazole